Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Prophase Labs ( (PRPH) ) is now available.
On December 29, 2025, ProPhase Labs, Inc. disclosed that it had failed to regain compliance with Nasdaq’s $1.00 minimum bid price requirement by the end of its second 180-day grace period on December 22, 2025, triggering a determination by Nasdaq staff to delist the company from the Nasdaq Capital Market. Nasdaq has notified ProPhase that trading in its common stock is scheduled to be suspended at the opening of business on January 5, 2026, after which a delisting filing will be made with the U.S. securities regulator; in response, the company plans to appeal the decision to a Nasdaq Hearings Panel and is simultaneously seeking to have its shares quoted on the OTC Markets, a move that could affect liquidity and visibility for shareholders while leaving the company’s longer-term listing status uncertain.
The most recent analyst rating on (PRPH) stock is a Hold with a $0.44 price target. To see the full list of analyst forecasts on Prophase Labs stock, see the PRPH Stock Forecast page.
Spark’s Take on PRPH Stock
According to Spark, TipRanks’ AI Analyst, PRPH is a Neutral.
The score is held down primarily by weak financial performance (shrinking revenue, losses, leverage, and negative cash flows) and very bearish technicals (price far below major averages with negative MACD). Offsetting factors include some potential catalysts discussed on the earnings call (collections initiative and BE-Smart interest) and recent corporate actions/LOI, but these are execution-dependent and do not outweigh current weakness.
To see Spark’s full report on PRPH stock, click here.
More about Prophase Labs
Average Trading Volume: 986,228
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.69M
Learn more about PRPH stock on TipRanks’ Stock Analysis page.